Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$56K Sell
380
-9
-2% -$1.35K 0.01% 276
2016
Q3
$65K Buy
389
+29
+8% +$4.9K 0.01% 252
2016
Q2
$55K Sell
360
-19
-5% -$2.95K 0.01% 272
2016
Q1
$57K Sell
379
-2
-0.5% -$297 0.01% 269
2015
Q4
$62K Sell
381
-32
-8% -$5.03K 0.01% 263
2015
Q3
$57K Sell
413
-113
-21% -$17.8K 0.01% 272
2015
Q2
$81K Sell
526
-430
-45% -$68.9K 0.02% 246
2015
Q1
$153K Buy
956
+84
+10% +$13.2K 0.03% 174
2014
Q4
$139K Buy
872
+721
+477% +$112K 0.03% 196
2014
Q3
$21K Hold
151
﹤0.01% 380
2014
Q2
$18K Buy
151
+23
+18% +$2.66K ﹤0.01% 413
2014
Q1
$16K Buy
+128
New +$15.5K ﹤0.01% 415

Other funds holding AMGN

Kanaly Trust's AMGN Position: Q4 2016 in Review

Kanaly Trust reduced its Amgen (AMGN) stake by 2.3% in Q4 2016, selling an estimated $1.35K and leaving 380 shares worth $56K. The position accounts for 0.01% of the portfolio, ranked #276.

Kanaly Trust first reported a position in AMGN in Q1 2014 and has held it in 12 quarters since. The position peaked at $153K in Q1 2015. 1,541 funds tracked by Wall St. Rank hold AMGN as of Q4 2016.

  • Kanaly Trust held 380 shares of Amgen worth $56K as of Q4 2016.
  • Kanaly Trust sold 9 Amgen shares in Q4 2016, an estimated $1.35K.
  • Amgen made up 0.01% of Kanaly Trust's portfolio in Q4 2016, its #276 holding.
  • Kanaly Trust first reported a position in Amgen in Q1 2014 and has held it in 12 quarters since.
  • Kanaly Trust's Amgen position peaked at $153K in Q1 2015.
  • 1,541 funds tracked by Wall St. Rank held Amgen as of Q4 2016.

Based on Kanaly Trust's 13F filing for Q4 2016, filed 23 Jan 2017.